Advanced search
Publication Cover
Journal of Mental Health Volume 11, 2002 - Issue 3
Submit an article Journal homepage
218
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Adherence to anti-psychotic medications and health behavior theories

Patrick W. Corrigan The University of Chicago, Tinley Park, Illinois, USA
Pages 243-254 | Published online: 06 Jul 2009

  • Aniador, X.F., Strauss, D.H., Yale, S.A. & German. J.M. (1991). Awareness of illness in schizophrenia. Schizophrenia Bulletin, 17, 113-132.
  • Aniador, X.F., Strauss, D.H., Yale, S.A., Flaum, M.M., Endicott, J. & German, J.M.( 1993). Assessment of insight in psychosis. American Journal of Psyschia-try, 150, 873-879.
  • Aniador, X.F., Flaum, M., Andreasen, N.C., Strauss. D.H., Yale, S.A., Clark, S.C. & German, J.M. (1994). Awareness of illness in schizophrenia and schizoaffective and mood disorders. Archives of General Psychiatry, 51, 826-836.
  • American Psychiatric Association (1997). Practice guidelines for the treatment of patients with schizo-phrenia. American Journal of Psychiatry. 154(Suppl), 1-63.
  • Anderson, C.M. Reiss, D.J., & Hogarty, G.E. (1986). Schizophrenia and the Family. New York: Guilford Press.
  • Appelbaum, P.S. & Gutheil, T.G. (1991). Clinical Handbook of Psychiatry and the Law (2nd Edn.). Baltimore: Williams and Wilkins Co.
  • Beasley C.M.Jr., Tollefson, G.,Tran, P., Satterlee, W., Sanger, T. & Hamilton, S. (1996). Olanzapine versus placebo and halperidol: Acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology, 14, 111-123.
  • Bellack, A.S. & DiClemente, C.C. (1999). Treating substance abuse among patients with schizophre-nia. Psychiatric Services, 50, 75-80.
  • Bondolfi, G., Dufour, H., Patris, M., Billeter, U., Eap, C. B. & Baumann, P. (1998). Risperidone versus clozapine in treatment-resistant chronic schizo-phrenia: A randomized double-blind study. Ameri-can Journal of Psychiatry, 155, 499-504.
  • Bowen, J.T. & Barnes, T.R.E. (1994). The clinical characteristics of schizophrenic patients consent-ing or not consenting to a placebo controlled trial of antipsychotic medication, Human Psychopharma-cology, 9, 423-433.
  • Brehm, J.W. (1966). A Theory of Psychological Reac-tance, New York: Academic Press.
  • Brehm, S.S. & Brehm, J.W. (1981). Psychological Reactance: A theory of freedom and control. New York: Academic Press.
  • Bush, C.T., Langford, M.W. & Rosen, P. (1990). Op-eration outreach: Intensive case management for severely psychiatrically disabled adults. Hospital and Community Psychiarty, 11, 647-649.
  • Calev, A. (1999). Assessment of Neuropsychological Function in Psychotic Disorders. Washington DC: American Psychiatric Press.
  • Chadwick, P. & Birchwood, M. (1994). The omnipo-tence of voices: A cognitive approach to auditory hallucinations. British Journal of Psychiarty, 164, 190-201.
  • Chadwick, P.D.J. & Lowe, C.F. (1990). A cognitive approach to measuring and modifying delusions, Behaviour, Research and Therapy, 32, 355-367.
  • Christensen, D., Williams, B. & Goldberg, H. (1997). Assessing compliance to anti-hypertensive medi-cations using computer-based pharmacy records. Medical Care, 35, 1164-1170.
  • Clare, L. & Birchwood, M. (1998). Social adjustment of patients living at home. In K. Mueser & N. Tarrier (Eds.), Handbok of Social Functioning in Schizophrenia, (pp. 39-51). Boston, MA: Allyn & Bacon.
  • Cohen, M.B. (1989). Social work practice with home-less mentally ill people: Engaging the client. Social Work, 34, 505-509.
  • Corrigan, P.W. & Garman, A.N. (1997). Some consid-erations for research on consumer empowerment and psychosocial interventions, Psychiatric Serv-ices, 48, 347-352.
  • Corrigan, P.W. & Kayton-Weinberg, D. (1993). Ag-gressive vers us problem-focused case management for the severely mentally ill. Community Mental Health Journal, 29, 449-458.
  • Corrigan, P.W., Liberman, R.P. & Engel, J.D. (1990). From nonconipliance to collaboration in the treat-ment of schizophrenia. Hospital and Community Psychiatry, 41, 1203-1211.
  • Corrigan, P.W., McCracken, S.G. & Holmes, E.P. (in press). Motivational interviews as goal assessment for persons with psychiatric disability. Community Mental Health Journal.
  • Corrigan, P.W. & Penn, D.L. (2001). Social cognition and schizophrenia. Washington DC: American Psychological Association.
  • Corrigan, P.W., Rao, D. & Lam, C. (1999). Psychiatric Rehabilitation. In F. Chan (Ed.), Case Manage-ment Desk Reference (pp. 527-564). Lake Zurich. IL: Vocational Consultants Press.
  • Corrigan, P.W. & Toomey, R. (1995). Interpersonal problem solving and information processing in schizophrenia. Schizophrenia Bulletin, 21, 395-404.
  • Corrigan, P.W., WaIlace, C.J., Schade, M.L. & Green, M.F. (1994). Learning medication self-manage-ment skills in schizophrenia: Relationships with cognitive deficits and psychiatric symptoms. Behavior Therapy, 25, 5-15.
  • Craig, T.K.J. (1998). Models of case management and their impact on social outcomes of severe mental illness. In K.T. Mueser & N. Tarrier(Eds.), Hand-book of Social Functioning in Schizophrenia (pp. 355-371). Boston, MA: Allyn & Bacon.
  • Cramer, J.A. & Rosenheck, R. (1998). Compliance with medication regimens for psychiatric and medi-cal disorders. Psychiatric Services, 49, 196-210.
  • Cuffel, B.J., Alford, J., Fischer, E.P. & Owen, R.R. (1996). Awareness of illness in schizophrenia and outpatient treatment adherence. Journal of Nerv-ous & Mental Disease, 184, 653-659.
  • Dowd, E.T., Wallbrown, F., Sanders, D. & Yesenosky, J.M. (1994). Psychological reactance and its rela-tionship to normal personality variables. Cognitive Therapy & Research, 18, 601-612.
  • Drury, V., Birchwood, M., Cochrane, R. & MacMillan, F. (1996). Cognitive therapy and recovery from acute psychosis: A controlled trial: I. Impact on psychotic symptoms. British Journal of Psychia-try, 169, 593-601.
  • Elliott, R. & Sahakian, B.J. (1995). The neuropsychol-ogy of schizophrenia: Relations with clinical and neurobiological dimensions. Psychological Medi-cine, 25, 581-594.
  • Ewart, C.K. (1991). Social action theory for public health psychology. American Psychologist, 46, 931-946.
  • FaIloon, I.R.H., Boyd J.L. & McGiIl, C.W. (1984). Family Care of Schizophrenia. New York: Guilford.
  • Fenton W.S., Blyler, C.R. & Heinssen, R.K. (1997). Determinants of medication compliance in schizo-phrenia: Empirical and clinical findings. Schizo-phrenia Bulletin, 23, 637-651.
  • Fishhein, M. & Ajzen, I. (1975). Misconception about the Fishbein model: Reflections on a study by Songer-Nocks. Journal of Experimental Social Psychology, 12, 579-584.
  • Fogarty, J.S. (1997). Reactance theory and patient noncompliance. Social Science and Medicine, 45, 1277-1288.
  • Garety, P.A., Kuipers, L., Fowler, D., Chamberlain, F. & Dunn, G. (1994). Cognitive behavioral therapy for drug-resistant psychosis. British Journal of Medical Psychology, 67, 259-271.
  • Garety, P.A. & Hemsley, D.R. (1997). Delusions: Investigations into the psychology of delusional reasoning. Hove, East Sussex: Psychology Press.
  • Ghaemi, S.N. & Pope, H.G. Jr. (1994). Lack of insight in psychotic and affective disorders: A review of empirical studies. Harvard Review of Psychiatry, 2, 22-33.
  • Glanz, K., Lewis, P.M. & Rimer, B.K. (1990). Health Behavior and Health Education: Theory, research and practice. San Francisco: Jossey-Bass Publish-ers.
  • Green, M.F. (1996). What are the functional conse-quences of neurocognitive deficits in schizophre-nia? American Journal of Psychiatry, 153, 321-330.
  • Hamilton, R.A. & Briceland, L.L. (1992). Use of prescription-refill records to assess patient compli-ance. American Journal of Hospital Pharmacy, 49. 1691-1696.
  • Herz, M.I. & Melville, C. (1980). Relapse in schizo-phrenia. American Journal of Psychiatry. 137. 801-805.
  • Hughes, I., Hill, B. & Budd, R.J. (1997). Compliance with anti-psychotic medication: from theory to practice, Journal of Mental Health, 6, 473-489.
  • Hornung, W.P., Klingberg, S. & Feldman, R. (1998). Collaboration with drug treatmentby schizophrenic patients with and without psychoeducational train-ing: Results of a 1-year follow-up. Acta Psychiatrica Scandinavica, 97, 213-219.
  • Janicak P.G. (1993). The relevance of clinical pharma-cokinetics and therapeutic drug monitoring: Anti-convulsant mood stabilizers and antipsychotics. Journal of Clinical Psychiatry, 54, S35-S41.
  • Jarboe, K.S. & Schwartz, S.K. (1999). The relationship between medication noncompliance and cognitive function in patients with schizophrenia. Journal of the American Psychiatric Nurses Association. 5. S2-S8.
  • Kanipman, O. & Lehtinen, K. (1999). Compliance in psychosis. Acta Psychiatrica Scandinavica, 100. 167-175.
  • Kane, J.M., Honigfeld, G., Singer, J. & Meltzer, H. (1988). Clozapine for the treatmentresistantschizo-phrenic: A double-blind comparison with chlo-rpromazine, Archives of General Psychiatry, 45, 789-796.
  • Kanter, J. (1989). Clinical case management: Defini-tion, principles, components. Hospital & Commu-nity Psychiatry, 40, 361-368.
  • Kelly, G.R., Mamon, J.A. & Scott. J.E. (1987). Utiliz-ing the health belief model in examining medica-tion compliance. Social Science & Medicine, 25, 1205-1211.
  • Kemp, R. & David, A. (1995). Insight and compliance. In B. Blackwell (Ed.), Compliance and the Treat-ment Alliance in Serious Mental Illness. Newark, NJ: Gordon and Breach Publishing Group.
  • Kemp, R., Hayward, P., Applewhaite, G., Everitt, B. & David, A. (1996). Compliance therapy in psy-chotic patients: Randomised controlled trial. Brit-ish Medical Journal, 312, 345-349.
  • Lin, I.E., Spiga, R. & Fortsch, W. (1979). Insight and adherence to medication in chronic schizophren-ics, Journal of Clinical Psychiatry, 40, 430-432.
  • Marder, S.R. & Meibach, R.L. (1994). Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825-835.
  • McGlashan, T.H. & Keats, C.J. (1989). Schizophrenia: Treatment Process and Outcome. Washington DC: American Psychiatric Press, Inc.
  • Meltzer, H.Y. & McGurk, S.R. (1999). The effects of clozapine, risperidone. and olanzapine on cogni-tive function in schizophrenia. Schizophrenia Bul-letin, 25, 233-255.
  • Miller, W.R. (1996). Motivational interviewing: Re-search, practice, and puzzles. Addictive Behaviors, 21, 835-842.
  • Miller, W.R. & Rollnick, S. (1991). Motivational Inter-viewing: Preparing people to change addictive behavior, New York: Guilford Press.
  • Mueser, K.T., Bond, G.R., Drake, R.E. & Resnick, S.G. (1998). Models of community care: A review of research on case management. Schizophrenia Bul-letin, 24, 37-74.
  • Pallanti, S., Quercioli, L., Pazzagli, A., Rossi, A., DellOsso, L., Pini, S. & Cassano, G.B. (1999). Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. American Journal of Psychia-try, 156, 1094.
  • Rimer, B.K.(1990).Perspectiveson intrapersonal theo-ries in health education and health behavior. In K. Glanz & F.M. Lewis (Eds.), Health Behavior and Health Education: Theory, research and practice (pp. 140-157). San Francisco, CA: Jossey-Bass. Inc.
  • Rogers, A., Day, J.C., Williams, B., Randall, F., Wood. P., Healy, D, & Bentall, R.P. (1998). The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. So-cial Science & Medicine, 47, 1313-1323.
  • Rosenstock, I.M. (1975). Patients' compliance with health regimens. Journal of the American Medical Association, 234, 402-403.
  • Rosenstock, I.M. (1990). The health belief model: Explaining health behavior through expectancies. In K. Glanz & F.M. Lewis (Eds.). Health Behavior and Health Education: Theories, research, and practice. San Francisco, CA: Jossey-Bass.
  • Roter, D., Hall, J. & Merisca, R. (1998). Effectiveness of interventions to improve patient compliance: A meta-analysis. Medical Care, 36, 1138-1161.
  • Ruscher, S., de Wit, R. & Mazimanian, D. (1997). Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatric Services, 48, 82-85.
  • Saykin, A.J., Gur, R.C., Gur, R.E. Mozley, P.D., Mozley, L.H., Resnick, S.M., Kester, D.B. & Stafiniak, P. (1991). Neuropsychological function in schizo-phrenia: Selective impairment in memory and learning. Archives of General Psychiatry, 48, 618-624.
  • Scott, J.E. & Dixon, L.B.(1995). Assertivecommunity treatmentand case management for schizophrenia. Schizophrenia Bulletin, 21, 657.
  • Smith, J.A., Hughes, I.C.T. & Budd, R.J. (1999). Non-compliance with anti-psychotic depot medication: Users' views on advantages and disadvantages. Journal of Mental Health, 8, 287-296.
  • Srebnik, D.S. & LaFond, J.Q. (1999). Advance direc-tives for mental health treatment, Psvchiatric Serv-ices, 50, 919-925.
  • Stein, L.I. & Test, M.A. (1980). Alternative to mental hospital treatment: I. Conceptual model, treatment program and clinical evaluation. Archive of Gen-eral Psychiatry, 37, 392-397.
  • Steiner, J. & Prochaska, A. (1997). The assessment of refill compliance using pharmacy records: Meth-ods, validity, and applications. Clinical Epidemiol-ogy, 50, 105-116.
  • Swanson, A.J., Pantalon, M.V. & Cohen, K.R. (1999). Motivational interviewing and treatment adher-ence among psychiatric and dually diagnosed pa-tients. Journal of Nervous & Mental Disease, 187, 630-635.
  • Tarder, N., Beckett, R., Harwood, S. & Baker, A. (1993). A trial of two cognitive-behavioural meth-ods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry, 162, 524-532
  • Tarrier, N., Yusupoff, L., McCarthy, E., Kinney, C. & Wittkowski, A. (1998). Some reasonswhy patients suffering from chronic schizophrenia fail to con-tinue in psychological treatment. Behavioural and Cognitive Psychotherapy, 26, 177-181.
  • Weiden, P.J. & Olfson, M. (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 21, 419-429.
  • Weiden, PJ., Olfson. M. & Essock, S. (1997). Medica-tion noncompliance in schizophrenia: Effects on mental health service policy. In B. Blackwell (Ed.). Treatment Compliance and the Therapeutic Alli-ance: Chronic Mental Illness (vol. 5) (pp. 35-60). Langhorne, PA: Harwood Academic Publishers.
  • Weinberger, D.R., Herman, K.F. & Zoc, R.F. (1986). Physiologic Dysfunction of Dorsolateral Prefron-tal Cortex in Schizophrenia. Washington, DC: Na-tional Institute of Mental Health.
  • Ziedonis, D.M. & Fisher, W. (1996). Motivation-based assessment and treatment of substance abuse in patients with schizophrenia. Directions'in Psychia-try, 16, 1-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.